Anika Therapeutics, Inc. (ANIK)
NASDAQ: ANIK · Real-Time Price · USD
9.60
+0.11 (1.16%)
Dec 5, 2025, 4:00 PM EST - Market closed
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
| Original Equipment Manufacturer Channel | 77.77M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Commercial Channel | 42.14M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Ostoarthritis Pain Management | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Ostoarthritis Pain Management Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Joint Preservation and Restoration | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Joint Preservation and Restoration Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Non-Orthopedic | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Non-Orthopedic Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
| United States | 82.45M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | -33.04% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe | 19.40M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe Growth | -10.68% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 18.06M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | -17.20% |
Log In |
Log In |
Log In |
Log In | Upgrade
|